Eir Diagnostics ApS: Financial statements 2022
CVR: 40339396
Eir Diagnostics ApS (CVR 40339396) has filed annual accounts for 2022. In 2022, the company reported a gross profit of DKK 1,661,104 and a net result of DKK -593,972 compared with DKK -469,005 the year before. That is an increase of 36.5% compared with the year before. Equity amounted to DKK 7,589,396. The solvency ratio was 65.5%. The company had 4 employees in the financial year.
- Gross Profit
- 1,661,104 kr.
- Profit/Loss
- -593,972 kr.
- Equity
- 7,589,396 kr.
- Total Assets
- 11,588,653 kr.
- Employees
- 4
Development
| Year | Revenue | Gross Profit | Profit/Loss | Equity | Employees |
|---|---|---|---|---|---|
| 2022 | - | 1.7 mio. | -594 t. | 7.6 mio. | 4 |
| 2021 | - | 1.2 mio. | -469 t. | 7.4 mio. | - |
| 2020 | - | 1.5 mio. | -369 t. | 5.2 mio. | - |
Keep an eye on Eir Diagnostics ApS
Get notified instantly about new financial statements, ownership changes, management changes and status changes.
Set up monitoringEvents in 2022
Eir Diagnostics ApS has published its annual report for 2021. Gross profit came to DKK 1,217,111, and the net result was DKK -469,005.
As of July 12, 2022, DELOITTE STATSAUTORISERET REVISIONSPARTNERSELSKAB has been appointed auditor of Eir Diagnostics ApS.
As of July 12, 2022, EY Godkendt Revisionspartnerselskab has stepped down as auditor of Eir Diagnostics ApS.
As of July 12, 2022, Morten Lodberg Petersen has left the board of directors of Eir Diagnostics ApS.
As of July 12, 2022, Preben Joffe has left the board of directors of Eir Diagnostics ApS.
As of July 12, 2022, Noemi Zsuzsanna Rozlosnik is registered as director of Eir Diagnostics ApS.
As of February 1, 2022, Tine Walldén Jespersen is registered as director of Eir Diagnostics ApS.
As of February 1, 2022, Michael Niels Døssing is registered as director of Eir Diagnostics ApS.
As of January 31, 2022, Michael Niels Døssing has stepped down as adm. dir. of Eir Diagnostics ApS.
About Eir Diagnostics ApS
Eir Diagnostics ApS is a Danish company of the type Anpartsselskab based in Vejle, founded in 2019. The company is registered under the industry Fremstilling af medicinske og dentale instrumenter samt udstyr hertil. The company was previously named AptaZense ApS. The management consists of Tine Walldén Jespersen. The company's owners include Danmarks Tekniske Universitet, KEMPHANSEN HOLDING ApS and PLASTISENS ApS. In 2025, the company reported a gross profit of DKK 370,098 and a net result of DKK -16,645,537 compared with DKK -455,658 the year before. Equity amounted to DKK -4,205,596.
